Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/10/2003US6576239 Angiogenic homing molecules and conjugates derived therefrom
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003US6576192 Fluoroionophores and their use in optical ion sensors
06/10/2003US6576116 Hybrid joule heating/electro-osmosis process for extracting contaminants from soil layers
06/10/2003US6576106 Electrophoretic patterning, fractionation, staining, visualizing, and optical scanning
06/10/2003US6576105 Pteridine analysis by capillary electrophoresis using laser-induced fluorescence detection
06/10/2003US6576101 Small volume in vitro analyte sensor
06/10/2003US6575303 Processing a product including aggregate materials and a volatile component
06/10/2003US6575021 Sample surface component for an instrument that measures viscosity and viscoelasticity
06/10/2003US6575018 Method for determining oil viscosity
06/10/2003US6575017 Fluid dose, flow and coagulation sensor for medical instrument
06/10/2003US6575013 Electronic odor sensor
06/10/2003CA2413625A1 Passive sample detection to initiate timing of an assay
06/10/2003CA2243247C Tagging of waterborne compositions with oil-soluble markers
06/10/2003CA2243077C Apparatus and method for analyzing power plant water chemistry
06/10/2003CA2137041C Assay for determining sensitivity to activated protein c
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2108579C Genetic markers for pig litter size
06/10/2003CA2107340C Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
06/10/2003CA2081879C Monoclonal antibodies to polyacrylate polymers
06/05/2003WO2003047037A2 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors
06/05/2003WO2003046798A1 Methods and systems for analyzing complex biological systems
06/05/2003WO2003046793A1 In siloco screening method for inhibitors of glutamyl-trna reductase
06/05/2003WO2003046684A2 Methods of data analysis using ranks
06/05/2003WO2003046609A2 System and method for irradiating a sample
06/05/2003WO2003046583A2 Individualization of therapy with anesthetics
06/05/2003WO2003046582A2 CANCER PROGNOSIS USING THYMOSIN β10 (Tβ10)
06/05/2003WO2003046581A2 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046579A2 Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease
06/05/2003WO2003046578A2 Method for the assessment and prognosis of sarcoidosis
06/05/2003WO2003046577A1 A system and method for automatic protein sequencing by mass spectrometry
06/05/2003WO2003046576A1 Fibrinogen biopolymer marker and its use for the screening of type ii diabetes
06/05/2003WO2003046575A1 Biopolymer marker indicative of normal human
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046573A2 Protein biopolymer markers predictive of insulin resistance
06/05/2003WO2003046572A2 Biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046571A2 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046569A1 Fibronectin precursor biopolymer marker predictive of alzheimers disease
06/05/2003WO2003046568A2 Protein biopolymer markers indicative of a disease state
06/05/2003WO2003046567A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046566A2 Pedf biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046565A2 Ig lambda biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046564A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046563A1 Food intolerance immunoassay
06/05/2003WO2003046562A1 Plastic substrate for microchips
06/05/2003WO2003046561A1 Method for diagnosing early and late lyme borreliosis
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046559A2 Individualization of therapy with antiviral agents
06/05/2003WO2003046558A2 Complement c3 precursor biopolymer markers predictive of type ii diabetes
06/05/2003WO2003046557A2 Hp biopolymer markers predictive of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046555A1 Determining antibody specificity
06/05/2003WO2003046554A1 Analysis of urea in a liquid by the use of an electronic tongue
06/05/2003WO2003046553A1 Diagnostics for chronic obstructive pulmonary disease
06/05/2003WO2003046552A2 Screening method for compounds that modulate neuronal activity
06/05/2003WO2003046550A1 Method and apparatus for the determination of water in cement
06/05/2003WO2003046549A1 Method for measuring concentration of chloroisocyanuric acid derivatives in water
06/05/2003WO2003046548A2 System and technique for detecting foreign material in meat
06/05/2003WO2003046538A1 Electrochemical detection of ischemia
06/05/2003WO2003046529A1 Quality and condition monitoring based on spectrum separating measurement
06/05/2003WO2003046518A1 Method and system of apparatus for extracting liquid from cellulose pulp of high pulp consistency for analysis purposes
06/05/2003WO2003046515A1 Apparatus for testing for particulate contaminants in depositories for mail-like articles
06/05/2003WO2003046514A2 Particle-based ligand assay with extended dynamic range
06/05/2003WO2003046511A2 Magneto-optical bio-discs and systems including related methods
06/05/2003WO2003046509A2 Capsule and tray systems for combined sample collection, archiving, purification, and pcr
06/05/2003WO2003046507A2 Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits
06/05/2003WO2003046505A2 Device for detecting carbon dioxide and method for determining a microbiological contamination of a fluid
06/05/2003WO2003046224A1 A blood-based assay for dysferlinopathies
06/05/2003WO2003046222A1 MAP4Ks AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
06/05/2003WO2003046221A1 Method for the specific identification of orthopoxvirus with the aid of a miniature biological chip.
06/05/2003WO2003046218A1 Methods for detecting cells with numerical chromosomal abnormalities
06/05/2003WO2003046216A1 Nanostructure, in particular for analysing individual molecules
06/05/2003WO2003046215A1 Method for detecting hybridization events in nucleic acids
06/05/2003WO2003046214A2 Method for analyzing translation-controlled gene expression
06/05/2003WO2003046212A2 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
06/05/2003WO2003046210A1 Method of sampling
06/05/2003WO2003046209A2 Method and biosensor for detecting macromolecular biopolymers
06/05/2003WO2003046207A2 Methods for inhibiting deacetylase activity
06/05/2003WO2003046205A2 Methods for identifying modulators of apoptosis
06/05/2003WO2003046202A2 Assaying apparatus, kit, and method for lipids and associated enzymes
06/05/2003WO2003046201A2 Detection and identification of enteric bacteria
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003046182A1 Human glioma antigen originating in testis
06/05/2003WO2003046180A2 Human cdnas and proteins and uses thereof
06/05/2003WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof
06/05/2003WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046153A2 The use of quantitative evolutionary trace analysis to determine functional residues
06/05/2003WO2003046148A2 Polypeptide quantitation
06/05/2003WO2003046144A2 Microscale immobilization of molecules using a hydrogel and methods of use thereof
06/05/2003WO2003046140A2 Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
06/05/2003WO2003046139A2 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
06/05/2003WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens
06/05/2003WO2003046130A2 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
06/05/2003WO2003046129A2 Compositions for the derivation of germ cells from stem cells and methods of use thereof
06/05/2003WO2003046128A2 Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus
06/05/2003WO2003046054A2 Copolymer libraries and production and use thereof
06/05/2003WO2003046052A1 Electroactive probe comprising a chelating agent and a metal ion
1 ... 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 ... 3937